0,996  0,000  Antipruritic
0,997  0,001  Eye irritation, high
0,997  0,001  Hypoxia-inducible factor 1 alpha inhibitor
0,995  0,001  Embryotoxic
0,995  0,001  Teratogen
0,995  0,001  Skin irritative effect
0,995  0,002  Antiallergic
0,996  0,003  Antiinflammatory
0,994  0,002  Toll-Like receptor agonist
0,993  0,002  Toll-Like receptor 7 agonist
0,993  0,002  Antiasthmatic
0,983  0,002  Carcinogenic
0,980  0,000  Antipruritic, allergic
0,978  0,000  Corticosteroid-like
0,979  0,002  TNF expression inhibitor
0,975  0,000  Glucocorticoid agonist
0,968  0,002  Chronic obstructive pulmonary disease treatment
0,963  0,000  Antipruritic, non-allergic
0,959  0,002  Allergic rhinitis treatment
0,958  0,004  Antiarthritic
0,947  0,002  CYP3A4 substrate
0,936  0,000  Arachidonic acid antagonist
0,934  0,002  Rhinitis treatment
0,924  0,001  Antieczematic
0,923  0,000  Lipocortins synthesis agonist
0,915  0,002  Diabetic retinopathy treatment
0,878  0,004  Antipsoriatic
0,871  0,002  Cardiodepressant
0,863  0,002  Androgen antagonist
0,857  0,004  Inflammatory Bowel disease treatment
0,847  0,003  Immunosuppressant
0,842  0,001  Glucocorticoid antagonist
0,828  0,004  NOS3 expression inhibitor
0,822  0,003  Proliferative diseases treatment
0,787  0,004  CYP3A4 inhibitor
0,777  0,014  Transcription factor NF kappa B inhibitor
0,765  0,006  Mutagenic
0,742  0,004  Antidiabetic symptomatic
0,738  0,003  Macular degeneration treatment
0,733  0,004  Antieczematic atopic
0,726  0,005  AR expression inhibitor
0,707  0,006  UGT1A9 substrate
0,707  0,017  Autoimmune disorders treatment
0,697  0,013  CYP2C9 substrate
0,671  0,012  Rheumatoid arthritis treatment
0,650  0,001  VEGF expression inhibitor
0,644  0,002  Interferon gamma antagonist
0,582  0,003  Interleukin 5 antagonist
0,574  0,011  CYP2C19 inhibitor
0,548  0,020  CYP2C19 substrate
0,523  0,008  ICAM1 expression inhibitor
0,512  0,017  NOS2 expression inhibitor
0,478  0,005  Cytokine production inhibitor
0,477  0,011  UGT1A1 substrate
0,479  0,017  Nitric oxide antagonist
0,470  0,013  UDP-glucuronosyltransferase substrate
0,497  0,051  Antidiabetic
0,497  0,051  Cyclophilin D inhibitor
0,442  0,006  NOS3 expression enhancer
0,438  0,003  Growth stimulant
0,430  0,007  UGT2B15 substrate
0,431  0,011  Contraceptive
0,490  0,077  Apoptosis agonist
0,417  0,005  Interleukin 4 antagonist
0,381  0,028  UGT1A6 substrate
0,366  0,013  Prostate disorders treatment
0,350  0,005  Contraceptive male
0,339  0,020  Osteoarthritis treatment
0,321  0,003  Androgen agonist
0,321  0,004  Antiemphysemic
0,359  0,056  Hepatic disorders treatment
0,312  0,019  Lipocortins synthesis antagonist
0,353  0,069  Antineoplastic (non-Hodgkin's lymphoma)
0,332  0,051  Antioxidant
0,300  0,049  Antiglaucomic
0,275  0,037  Hepatoprotectant
0,308  0,078  Immunomodulator
0,296  0,068  Radioprotector
0,259  0,042  VCAM1 expression inhibitor
0,263  0,047  Antihypotensive
0,246  0,036  Prostatic (benign) hyperplasia treatment
0,266  0,057  DNA synthesis inhibitor
0,194  0,004  Mineralocorticoid receptor antagonist
0,216  0,034  Acute respiratory distress syndrome (ARDS) treatment
0,176  0,010  Aromatase inhibitor
0,206  0,041  Antiacne
0,247  0,092  Spasmolytic
0,160  0,013  Anabolic
0,132  0,003  Nitric oxide donor
0,151  0,023  Breast cancer-resistant protein inhibitor
0,138  0,011  T cell inhibitor
0,247  0,131  Sodium/bile acid cotransporter inhibitor
0,126  0,013  Na+ K+ transporting ATPase inhibitor
0,223  0,112  UGT2B4 substrate
0,127  0,018  Antiprotozoal activity enhancer
0,109  0,003  Progesterone agonist
0,237  0,133  Angiogenesis inhibitor
0,213  0,112  Immunostimulant
0,196  0,096  Antineoplastic (lymphoma)
0,192  0,095  Antiulcerative
0,130  0,033  Interleukin 2 antagonist
0,197  0,101  Antineoplastic (glioma)
0,137  0,044  Gout treatment
0,134  0,049  Contraceptive female
0,095  0,009  Progesterone antagonist
0,138  0,059  Antihemorrhagic
0,158  0,082  UGT2B7 substrate
0,128  0,053  Alcohol dehydrogenase substrate
0,092  0,022  Antitreponemal
0,168  0,104  Antineoplastic (glioblastoma multiforme)
0,121  0,059  Microtubule formation inhibitor
0,139  0,078  Ca2+-transporting ATPase inhibitor
0,107  0,048  UGT2B11 substrate
0,153  0,095  UGT2B10 substrate
0,102  0,046  Antineoplastic antibiotic
0,141  0,088  UGT2B9 substrate
0,106  0,057  Bronchodilator
0,060  0,015  Microtubule stabilization
0,152  0,117  Systemic lupus erythematosus treatment
0,048  0,013  Glucose-6-phosphate dehydrogenase inhibitor
0,096  0,065  Dementia treatment
0,094  0,064  Vascular dementia treatment
0,160  0,133  Antineoplastic (cervical cancer)
0,140  0,112  Cytotoxic
0,041  0,014  Tubulin agonist
0,076  0,049  Cushing's syndrome treatment
0,124  0,101  Chemopreventive
0,162  0,142  Tumour necrosis factor alpha release inhibitor
0,203  0,183  Antineoplastic (breast cancer)
0,142  0,124  Antiviral (Influenza)
0,035  0,018  RNA-directed RNA polymerase stimulant
0,159  0,146  Cytostatic
0,142  0,130  P-glycoprotein inhibitor
0,011  0,002  Transcortin receptor antagonist
0,136  0,129  Interleukin antagonist
0,101  0,096  Estrogen antagonist
0,159  0,154  Antineoplastic (liver cancer)
0,095  0,092  DNA polymerase I inhibitor

